Chargement en cours...
Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment
Background: Cognitive impairment is prevalent in Parkinson's disease (PD), affecting 15–20% of patients at diagnosis. α-synuclein expression and genetic polymorphisms of Apolipoprotein E (ApoE) have been associated with the presence of cognitive impairment in PD although data have been inconsis...
Enregistré dans:
| Publié dans: | Front Neurosci |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5742342/ https://ncbi.nlm.nih.gov/pubmed/29326545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2017.00712 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|